Halozyme Therapeutics Inc (NASDAQ:HALO)

19.13
BATS BZX Real-Time Price
As of 11:23am ET
 +0.22 / +1.16%
Today’s Change
11.41
Today|||52-Week Range
21.48
-5.58%
Year-to-Date

Today’s Trading

Previous close18.91
Today’s open18.93
Day’s range18.82 - 19.16
Volume12,095
Average volume (3 months)886,964
Market cap$2.9B
Data as of 11:23am ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-290.40%
Earnings growth (next 5 years)+55.00%
Revenue growth (last year)+115.84%
P/E ratio36.8
Price/Sales8.90
Price/Book13.62

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.37+1.21%
BPMCBlueprint Medicines ...+1.45+2.14%
XLRNAcceleron Pharma Inc+0.22+0.60%
XONIntrexon Corp+0.45+2.73%
Data as of 11:27am ET, 06/19/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$316.6M
Annual profit (last year)$63.0M
Net profit margin19.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts